The size variation of red blood cells and the ratio of different cell types in the blood could be used to predict the outcome of surgery in epithelial ovarian cancer patients, according to recent research.
Developed by Chinese researchers in collaboration with the Mayo Clinic in Rochester, Minnesota, the approach could help identify patients who may need to be monitored more closely and offered more intensive therapies.
The study, “Preoperative red cell distribution width and neutrophil-to-lymphocyte ratio predict survival in patients with epithelial ovarian cancer,” was published in the journal Scientific Reports.According to data from the American Cancer Society, from 85 to 90 percent of ovarian tumors are diagnosed as epithelial ovarian cancer (EOC). "When someone says that they had ovarian cancer, they usually mean that they had this type of cancer," the ACS says. And information from the National Cancer Institute indicates that even though EOC is about one-tenth as common as breast cancer, it is the most lethal gynecologic malignancy among U.S. women.
Complete blood counts and markers of inflammation that are derived from these counts were already known to be linked to outcomes in epithelial ovarian cancer